We are an interdisciplinary team of machine learners, data scientists, pathologists, biologists, software engineers, regulatory experts and business professionals.
PROF. FREDERICK KLAUSCHEN
Co-Founder & Lead Medical Adviser
Frederick has been researching AI in pathology since 2012 and initiated Aignostics. He is a professor of Pathology and Director of the Institute of Pathology at Ludwig-Maximilians-Universität Munich, but also a trained physicist and inventor. Moreover, Frederick is the topic leader at WHO for AI in healthcare (AI4Health) and a member of the International Academy of Pathology, amongst other roles.
PROF. KLAUS-ROBERT MÜLLER
Co-Founder & Lead Technical Adviser
Klaus is a seasoned AI pioneer and played a pivotal role in developing the technology behind Aignostics. He is the chair of the machine learning group at TU Berlin, a principal scientist at Google Brain, and director of the Berlin Machine Learning Center and the Berlin Institute for the Foundations of Learning and Data (BIFOLD) amongst other roles. Klaus is also an external member of the Max Planck Society and a member of the German National Academy of Sciences and the Berlin Brandenburg Academy of Sciences.
Co-Founder & CEO
Viktor is a former McKinsey & Company Consultant and also gained experience as investment professional in the tech and healthcare space with Bridgepoint in Germany and the UK. He holds a BSc from Vienna University of Economics, an MSc from London Business School, and an MBA from INSEAD. Viktor is also a self-taught software developer since his early youth.
DR. MAXIMILIAN ALBER
Co-Founder & CTO
Max holds a PhD in Machine Learning from TU Berlin, and a BSc and MSc in Computer Science from FU Berlin. He gained professional experience as Software Engineer at various startups, Fraunhofer, and Google and is an expert in explainable AI. Max was also a member of the Berlin Big Data Centre and the Berlin Centre of Machine Learning.
Jessica Riley, PhD
Chief Business Officer
Jessica is an expert in precision diagnostics having worked for various technology and diagnostics companies in the EU and USA; Qiagen (formerly DxS Ltd), Leica Biosystems, Guardant Health and PathAI. She has contributed to bringing companion diagnostics to various major markets from transaction through to regulatory approval and commercial launch across multiple technology platforms as well as advised biopharma companies on companion diagnostic partnering strategy.